ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

No reported Financing Cash Flow figures are available to summarize.

Financing Cash Flow history

Currency unavailable · from the cash flow

No Financing Cash Flow data reported for this period type.

Financing Cash Flow vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Financing Cash Flow for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$489.54M USD+101.0%+93.7%681.8%
STOKStoke Therapeutics, Inc.LTM Mar 2026$180.34M USD+37.9%+28.0%562.2%
PRMEPrime Medicine, Inc.LTM Mar 2026$145.91M USD+227.5%-5.8%3616.9%
BNTCBenitec Biopharma Inc.LTM Mar 2026$106.87M USD-1.1%——
RNAAtrium Therapeutics, Inc.FY2025$42.57M USD——228.7%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$1.8M USD-109.8%—4.0%
PRQRProQR Therapeutics N.V.LTM Mar 2026€1.63M EUR-102.3%-61.5%12.2%
MGTXMeiraGTx Holdings plcLTM Mar 2026$446K USD-99.2%-49.5%0.6%
SLNSilence Therapeutics plcLTM Mar 2026$911.01 USD—-93.4%0.1%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-1.1%-27.7%120.4%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.